For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
L-(+)-Ergothioneine (CAS 58511-63-0) is a naturally occurring amino acid and is a thiourea derivative of histidine, containing a sulfur atom on the imidazole ring. This compound is made in relatively few organisms, notably Actinobacteria, Cyanobacteria, and certain fungi.
LPI (LP Information)' newest research report, the "L-(+)-Ergothioneine Industry Forecast" looks at past sales and reviews total world L-(+)-Ergothioneine sales in 2022, providing a comprehensive analysis by region and market sector of projected L-(+)-Ergothioneine sales for 2023 through 2029. With L-(+)-Ergothioneine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world L-(+)-Ergothioneine industry.
This Insight Report provides a comprehensive analysis of the global L-(+)-Ergothioneine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on L-(+)-Ergothioneine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global L-(+)-Ergothioneine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for L-(+)-Ergothioneine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global L-(+)-Ergothioneine.
The global L-(+)-Ergothioneine market size is projected to grow from US$ 11 million in 2022 to US$ 71 million in 2029; it is expected to grow at a CAGR of 71 from 2023 to 2029.
There are fewer producers in the sector, with Tetrahedron and Mironova Labs taking a higher share of revenue, at 58.64% and 34.77% respectively in 2019.
This report presents a comprehensive overview, market shares, and growth opportunities of L-(+)-Ergothioneine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Biosynthesis
- Chemical Synthesis
- Biological Fermentation
Segmentation by application
- Medical
- Cosmetics
- Food Industry
- Others
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Tetrahedron
- Mironova Labs
- Blue California
Key Questions Addressed in this Report
What is the 10-year outlook for the global L-(+)-Ergothioneine market?
What factors are driving L-(+)-Ergothioneine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do L-(+)-Ergothioneine market opportunities vary by end market size?
How does L-(+)-Ergothioneine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?